Mark Mallon - Net Worth and Insider Trading
Mark Mallon Net Worth
The estimated net worth of Mark Mallon is at least $3 Million dollars as of 2024-09-24. Mark Mallon is the CEO of Ironwood Pharmaceuticals Inc and owns about 470,605 shares of Ironwood Pharmaceuticals Inc (IRWD) stock worth over $2 Million. Mark Mallon is also the CEO of NeoGenomics Inc and owns about 72,736 shares of NeoGenomics Inc (NEO) stock worth over $1 Million. Details can be seen in Mark Mallon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Mallon has not made any transactions after 2021-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Mallon
Mark Mallon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Mallon owns 2 companies in total, including Ironwood Pharmaceuticals Inc (IRWD) , and NeoGenomics Inc (NEO) .
Click here to see the complete history of Mark Mallon’s form 4 insider trades.
Insider Ownership Summary of Mark Mallon
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2021-02-26 | Executive Senior Advisor |
| NEO | NeoGenomics Inc | 2021-12-06 | director & Chief Executive Officer |
Mark Mallon Latest Holdings Summary
Mark Mallon currently owns a total of 2 stocks. Among these stocks, Mark Mallon owns 470,605 shares of Ironwood Pharmaceuticals Inc (IRWD) as of February 26, 2021, with a value of $2 Million and a weighting of 62.56%. Mark Mallon also owns 72,736 shares of NeoGenomics Inc (NEO) as of December 6, 2021, with a value of $1 Million and a weighting of 37.44%.
Latest Holdings of Mark Mallon
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IRWD | Ironwood Pharmaceuticals Inc | 2021-02-26 | 470,605 | 4.08 | 1,920,068 |
| NEO | NeoGenomics Inc | 2021-12-06 | 72,736 | 15.80 | 1,149,229 |
Holding Weightings of Mark Mallon
Mark Mallon Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Mallon has made a total of 3 transactions in Ironwood Pharmaceuticals Inc (IRWD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Ironwood Pharmaceuticals Inc is the sale of 30,675 shares on February 26, 2021, which brought Mark Mallon around $279,449.
According to the SEC Form 4 filings, Mark Mallon has made a total of 1 transactions in NeoGenomics Inc (NEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in NeoGenomics Inc is the acquisition of 17,000 shares on December 6, 2021, which cost Mark Mallon around $520,710.
Insider Trading History of Mark Mallon
- 1
Mark Mallon Trading Performance
GuruFocus tracks the stock performance after each of Mark Mallon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Mallon is -38.25%. GuruFocus also compares Mark Mallon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Mallon within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Mallon's insider trading performs compared to the benchmark.
Performance of Mark Mallon
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.97 | | | | | |
| Relative Return to S&P 500(%) | -10.24 | | | | | |
Mark Mallon Ownership Network
Mark Mallon Owned Company Details
What does Ironwood Pharmaceuticals Inc do?
Who are the key executives at Ironwood Pharmaceuticals Inc?
Mark Mallon is the Executive Senior Advisor of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include Principal Accounting Officer Ronald Silver , Chief Legal Officer Minardo John , and SVP & Chief Business Officer Andrew Davis .
Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary
Over the past 18 months, Mark Mallon made no insider transaction in Ironwood Pharmaceuticals Inc (IRWD). Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 374,691 shares made by Thomas A Mccourt , a net sale of 81,739 shares made by Minardo John , and a net sale of 42,163 shares made by Andrew Davis .
In summary, during the past 3 months, insiders sold 13,017 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 13,017 shares. During the past 18 months, 689,346 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 635,670 shares.
Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ironwood Pharmaceuticals Inc Insider Transactions
Mark Mallon Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Mallon. You might contact Mark Mallon via mailing address: C/o Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston Ma 02110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
